Lyell Immunopharma shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $490k | 355k | 1.38 |
| 2024-06-30 | $37k | 26k | 1.44 |
| 2024-03-31 | $76k | 34k | 2.22 |
| 2023-09-30 | $51k | 35k | 1.48 |
| 2022-12-31 | $56k | 16k | 3.48 |
| 2022-03-31 | $237k | 47k | 5.04 |
| 2021-06-30 | $495k | 31k | 16.23 |